产前糖皮质激素与儿童严重感染风险的关联:全国性队列研究
该研究基于台湾2008年1月1日至2019年12月31日的全国健康保险研究数据库、出生通报数据库及母婴健康数据库,纳入1 960 545对孕妇及其单胎子代,其中45 232名儿童暴露于产前糖皮质激素、1 915 313名未暴露。主要结局为出生后3、6、12个月内总体严重感染、脓毒症、肺炎、急性胃肠炎等感染的发生率。结果显示,暴露组在出生后6个月内总体严重感染(调整HR 1.32,95%CI 1.18至1.47,P<0.001)、脓毒症(1.74,1.16至2.61,P=0.01)、肺炎(1.39,1.17至1.65,P<0.001)和急性胃肠炎(1.35,1.10至1.65,P<0.001)风险显著高于未暴露组;出生至12个月时上述结局风险亦显著升高。作者认为,开始治疗前应仔细权衡产前糖皮质激素的围产期获益与罕见但严重的远期感染风险。
要点
- 产前暴露一疗程糖皮质激素的儿童,出生后6个月内总体严重感染风险显著升高(调整HR 1.32,95%CI 1.18至1.47,P<0.001)。
- 同一队列中,出生后6个月内脓毒症风险显著升高(调整HR 1.74,95%CI 1.16至2.61,P=0.01),肺炎风险升高(1.39,1.17至1.65,P<0.001),急性胃肠炎风险升高(1.35,1.10至1.65,P<0.001)。
- 出生至12个月时,总体严重感染(P<0.001)、脓毒症(P=0.02)、肺炎(P<0.001)和急性胃肠炎(P<0.001)风险仍显著升高。
- 同胞匹配队列结果与全队列相当,出生后6个月(P=0.01)和12个月(P=0.04)内脓毒症风险显著增加。
- 作者认为,开始产前糖皮质激素治疗前,应仔细权衡围产期获益与罕见但严重的远期感染风险。
适用人群与场景
- 2008年1月1日至2019年12月31日台湾全国健康保险研究数据库、出生通报数据库及母婴健康数据库中所有孕妇及其单胎子代,共1 960 545对。
- 暴露组为接受一疗程产前糖皮质激素的45 232名儿童,未暴露组为1 915 313名儿童。
研究设计与关键结果
- 研究类型:全国性队列研究;样本量1 960 545名单胎儿童,暴露于产前糖皮质激素45 232名,未暴露1 915 313名。
- 出生后6个月内,暴露组总体严重感染风险显著高于未暴露组(调整HR 1.32,95%CI 1.18至1.47,P<0.001),脓毒症(调整HR 1.74,95%CI 1.16至2.61,P=0.01),肺炎(调整HR 1.39,95%CI 1.17至1.65,P<0.001),急性胃肠炎(调整HR 1.35,95%CI 1.10至1.65,P<0.001)。
- 出生至12个月时,暴露组总体严重感染(P<0.001)、脓毒症(P=0.02)、肺炎(P<0.001)、急性胃肠炎(P<0.001)风险显著高于未暴露组。
- 同胞匹配队列中,结果与全队列相当,出生后6个月(P=0.01)和12个月(P=0.04)内脓毒症风险显著增加。
证据类型、等级与局限
- 证据类型:全国性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,开始产前糖皮质激素治疗前,应仔细权衡围产期获益与罕见但严重的远期感染风险。
- 本研究提示,产前糖皮质激素暴露儿童在出生后12个月内严重感染风险升高,临床随访中需关注感染相关表现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.
DESIGN: Nationwide cohort study.
SETTING: National Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.
PARTICIPANTS: 1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.
MAIN OUTCOME MEASURES: Incidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.
RESULTS: The study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.
CONCLUSIONS: This nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
参考来源
- Yao TC, Chang SM, Wu CS, et al. Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study. BMJ. 2023. PMID: 37532264. doi:10.1136/bmj-2023-075835
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。